Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Kumari

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|January 16, 2021
β-lactam antibiotics to tame down molecular pathways of Alzheimer's diseaseShilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology|December 22, 2022
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's diseaseMaanvi, Shilpa Kumari, Rahul Deshmukh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisShilpa Kumari, Rahul Renukadas Deshmukh
Inflammopharmacology|January 14, 2025
Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's diseaseShilpa Kumari, Kajal Bagri, Rahul Deshmukh
International Journal of Biological Macromolecules|March 7, 2024
Safe and sustainable food packaging: Argemone albiflora mediated green synthesized silver-carrageenan nanocomposite filmsShilpa Kumari, Asha Kumari, Rahul Sharma
Neuroscience|November 1, 2025
Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's diseaseVanya, Shilpa Kumari, Kajal Bagri, et al.
Inflammopharmacology|July 27, 2025
Traumatic Brian Injury (TBI) unraveled: molecular disruptions and therapeutic avenuesNisha Kumari, Kajal Bagri, Shilpa Kumari, et al.
Inflammopharmacology|March 28, 2025
Ceramide: a central regulator in Alzheimer's disease pathogenesisPriyanka Choudhary, Shilpa Kumari, Kajal Bagri, et al.
Natural Product Research|April 9, 2026
An antiproliferative bioactive flavanol from <i>Vachellia nilotica nilotica</i> (L.) P.J.H. Hurter & Mabb. against Osteosarcoma cell line: An <i>in-vitro</i> and <i>in-silico</i> studyNeha Verma, Mohini Singh, Shilpa Kumari, et al.
Pharmaceutical Nanotechnology|October 15, 2025
Design and Evaluation of Econazole-Loaded Nanostructured Lipid Carriers for Ocular Treatment of Fungal Keratitis: In vitro and Ex vivo StudiesSandhya Jaiswal, Shilpa Kumari, Anjoo Kamboj, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|January 16, 2021
β-lactam antibiotics to tame down molecular pathways of Alzheimer's diseaseShilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology|December 22, 2022
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's diseaseMaanvi, Shilpa Kumari, Rahul Deshmukh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisShilpa Kumari, Rahul Renukadas Deshmukh
Inflammopharmacology|January 14, 2025
Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's diseaseShilpa Kumari, Kajal Bagri, Rahul Deshmukh
International Journal of Biological Macromolecules|March 7, 2024
Safe and sustainable food packaging: Argemone albiflora mediated green synthesized silver-carrageenan nanocomposite filmsShilpa Kumari, Asha Kumari, Rahul Sharma
Neuroscience|November 1, 2025
Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's diseaseVanya, Shilpa Kumari, Kajal Bagri, et al.
Inflammopharmacology|July 27, 2025
Traumatic Brian Injury (TBI) unraveled: molecular disruptions and therapeutic avenuesNisha Kumari, Kajal Bagri, Shilpa Kumari, et al.
Inflammopharmacology|March 28, 2025
Ceramide: a central regulator in Alzheimer's disease pathogenesisPriyanka Choudhary, Shilpa Kumari, Kajal Bagri, et al.
Natural Product Research|April 9, 2026
An antiproliferative bioactive flavanol from <i>Vachellia nilotica nilotica</i> (L.) P.J.H. Hurter & Mabb. against Osteosarcoma cell line: An <i>in-vitro</i> and <i>in-silico</i> studyNeha Verma, Mohini Singh, Shilpa Kumari, et al.
Pharmaceutical Nanotechnology|October 15, 2025
Design and Evaluation of Econazole-Loaded Nanostructured Lipid Carriers for Ocular Treatment of Fungal Keratitis: In vitro and Ex vivo StudiesSandhya Jaiswal, Shilpa Kumari, Anjoo Kamboj, et al.
Pageof 3